NRI

KABRA DRUGS SHARE PRICE

Sector Pharmaceuticals
BSE 524322
11.63
0.55 (4.96 %)
Buy
B
Sell
S
BSE

Overview

Day Low

10.56

Day High

11.63

52 Week Low

7.54

52 Week High

11.63

All Time Low

0.52

All Time High

21.90

Open

11.63

Close

11.08

Volume

419,518

Mkt cap (Cr)

27.57

P/E ratio

0.00

P/B ratio

0.91%

Div yield

0.00%

6M return

21.27%

1Y return

54.24%

1D 1W 1M 3M 6M 1Yr 3Yr 5Yr 10Yr Max
Price PE Ratio
 

We appreciate your patience. Your content is on the way.

SWOT Analysis

  • S
  • W
  • O
  • T

Technical Analysis

Moving Averages

EMA SMA
 

We appreciate your patience. Your content is on the way.

11.63 4.96%

Current Price

  • Bullish Moving Averages
  • Bearish Moving Averages

Resistance and support

 

We appreciate your patience. Your content is on the way.

Company Financials

  • Profit and loss statement
  • Balance sheet
  • Quarterly Result
  • Ratio
 

We appreciate your patience. Your content is on the way.

Quick Results Snapshot

 

We appreciate your patience. Your content is on the way.

Shareholding Pattern

Summary

 

We appreciate your patience. Your content is on the way.

 

We appreciate your patience. Your content is on the way.

Historical Promoter Summary

 

We appreciate your patience. Your content is on the way.

Promoter Holding(%)

Historical FII Holdings

 

We appreciate your patience. Your content is on the way.

FII Holding(%)

Historical MF Holdings

 

We appreciate your patience. Your content is on the way.

MF Holding(%)

Stocks Comparison
Table Chart

 

We appreciate your patience. Your content is on the way.

Corporate Action

  • Announcement
  • Board Meeting
  • Dividend
  • Split
  • Rights
  • Events

Insider & Institutional Activity

  • Bulk Block Deals
  • Insider Trading & SAST
 

We appreciate your patience. Your content is on the way.

About Kabra Drugs Ltd

Stock PE (TTM)

0

Promoter Holding

0%

Book Value

10.5817

ROCE

0%

ROE

0%

Kabra Drugs Ltd was incorporated as a Limited Company on August 22, 1989. The Company has set up a Unit at Indore for manufacturing of Ether derivatives which includes Diethyl Ether (Anesthesia), Solvent Ether, Ethyl Chloride Spray (General Anesthesia) and Surgical. The commercial production commenced in 1991. Kabra Drugs Limited is the only manufacturer of Ether derivatives in the State of M.P. tHE Company is presently engaged in the business of Permaculture manufacturing and trading in pharma related products. The latest addition to the product line is the range of disinfectants which includes hand wash gel, hand sanitizer and antimicrobial gel. In India there are very few manufacturers who are manufacturing the said products. The company is the sole manufacturer of antimicrobial hand wash gel and other disinfectant products in India. The company is also a registered supplier to the Ministry of Defence. With manufacturing and regular supply in the domestic market for injectables, soft gelatin capsules and liquids (oral and external especially alcohol products) the company now looks at the global market. A number of new products have been developed for the same. Kabra Drugs are known to meet the diverse medical needs of patients in Emerging Markets in an innovative, socially responsible and commercially viable manner. Their products are manufactured at state of the art ultra modern plants with latest equipments backed by professional technocrats. These are WHO-GMP, cGMP & Schedule `M` approved facilities which also helps to get business approvals for Government, Semi- Government under takings , big institutions and other N.G.O`s. Besides, they are also actively involved in trading and marketing of biological API`s and Biochemicals. Due to scarcity of working capital funds, the Company is not able to perform any business activities. To make the Company operational, the Board is making its best effort to implement the cost reduction measures to the extent feasible. Several cost cutting measures have already been undertaken by the Company.

Kabra Drugs share price as on 14 May 2025 is Rs. 11.63. Over the past 6 months, the Kabra Drugs share price has increased by 21.27% and in the last one year, it has increased by 54.24%. The 52-week low for Kabra Drugs share price was Rs. 7.54 and 52-week high was Rs. 11.63.

Read More
Registered Office  
Registrars  
Management  
Listing Info  

524322

INE323K01017

Sep

Kabra Drugs Ltd FAQs

You can buy Kabra Drugs Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Kabra Drugs Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of May 12, 2025 01:57 PM the closing price of Kabra Drugs Ltd was Rs.11.63.

The latest PE ratio of Kabra Drugs Ltd as of May 12, 2025 01:57 PM is 0.00

The latest PB ratio of Kabra Drugs Ltd as of May 12, 2025 01:57 PM is 0.91

The 52-week high of Kabra Drugs Ltd share price is Rs. 11.63 while the 52-week low is Rs. 7.54

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of May 12, 2025 01:57 PM, the market cap of Kabra Drugs Ltd stood at Rs. 27.57 Cr.

Market Outlook

View all
 

We appreciate your patience. Your content is on the way.